Inspires a love for learning in everyone.
This comment is not public.
Professor Isuru Ranasinghe is a Senior Staff Specialist Cardiologist and Associate Professor in Cardiology at The Prince Charles Hospital and the Northside Clinical Unit of the Faculty of Medicine, The University of Queensland. He holds the degrees MBChB, MMed(Clin Epi), PhD, and is a Fellow of the Cardiac Society of Australia and New Zealand (FCSANZ) and the European Society of Cardiology (FESC). His primary research interests encompass clinical cardiology, cardiovascular epidemiology, and healthcare safety and quality. Dr. Ranasinghe leads prominent research initiatives, including ORION: Leveraging Big Data to Inform Nationwide Cardiovascular Health Outcomes, a national data linkage study utilizing cardiovascular hospitalisation data from Australian States and Territories as well as New Zealand. He also directs the SAFER Hospitals project, a nationwide investigation employing linked hospitalisation data to assess adverse events, mortality, unplanned readmissions, and associated costs across Australian hospitals. Additionally, he oversees projects such as Remote monitoring of cardiac implantable electronic devices using an exception-based model of care and Outcomes of cardiovascular care in regional and remote Australian communities.
Dr. Ranasinghe has been awarded competitive fellowships including the NHMRC Postgraduate Scholarship, NHMRC Neil-Hamilton-Fairley Early Career Fellowship, National Heart Foundation of Australia Future Leader Fellowship, and the Advancing Queensland Clinical Research Fellowship. His research portfolio includes substantial funding from sources such as NHMRC IDEAS Grants for Safety, Effectiveness of Care, and Resource Use Associated with Elective Hospital Procedural Care (2025-2029) and Safety, effectiveness of care and resource use among Australian hospitals (2021-2026), alongside National Heart Foundation Vanguard Grants and Queensland Health fellowships. Notable publications include 'Long-term outcomes after hospitalization for atrial fibrillation or flutter' (2024, European Heart Journal), 'Hospital costs for unplanned re-admissions within 30 days of hospitalisations with heart failure, Australia, 2013–2017: a retrospective cohort study' (2024), 'Timing, diagnosis, and potential preventability of 30-day unplanned readmissions after a heart failure hospitalisation' (2025), 'Differences between sexes in STEMI treatment and outcomes with contemporary primary PCI' (2024), and 'Long-Term Survival and Life Expectancy Following an Acute Heart Failure Hospitalisation in Australia and New Zealand' (2022). With 132 works documented in UQ eSpace from 2009 to 2025, his contributions significantly influence cardiovascular care quality, outcomes research, and health policy in Australia.
